SCHEMBL14099640

SCHEMBL14099640

CCCNc1ncccc1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
KDM4E B2RXH2 1/20 0.59
HPGD P15428 1/20 0.59
HSD17B10 Q99714 1/20 0.59
APP P05067 2/20 0.49
TLR7 Q9NYK1 3/20 0.47
TLR8 Q9NR97 3/20 0.47
UTS2R Q9UKP6 1/20 0.44
PDE5A O76074 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
LATS1 O95835 4/20 0.40
LATS2 Q9NRM7 3/20 0.40
BACE1 P56817 1/20 0.38
CCNC P24863 1/20 0.37
HTT P42858 1/20 0.37
CDK8 P49336 1/20 0.37
BCHE P06276 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11263883 0.88 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDHSD17B10TLR7
SCHEMBL11578570 0.85 GRM5 (0.43) ALDH1A1KDM4EHPGDHSD17B10TLR7
SCHEMBL3825817 0.85 GRM5 (0.43) ALDH1A1KDM4EHPGDHSD17B10TLR7
Hydrochloric Acid SCHEMBL10559703 0.83 GRM5 (0.42) ALDH1A1KDM4EHPGDHSD17B10TLR7
SCHEMBL7360763 0.83 PRKCH (0.48) ALDH1A1KDM4EHPGDHSD17B10TLR7
SCHEMBL2943749 0.81 KDM4E (0.47) ALDH1A1KDM4EHPGDHSD17B10CA12
SCHEMBL4279158 0.81 CYP2C19 (0.54) ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL9977933 0.81 UTS2R (0.48) ALDH1A1KDM4EHPGDHSD17B10TLR7
SCHEMBL29306393 0.80 TLR8 (0.43) ALDH1A1KDM4EHPGDHSD17B10TLR7
SCHEMBL6442879 0.79 KDM4E (0.57) ALDH1A1KDM4EHPGDHSD17B10UTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322309-B1 HIGH AFFINITY SMALL MOLECULE C5A RECEPTOR MODULATORS NEUROGEN CORP (US) 2008-08-13 EP disclosed
US-7271270-B2 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION (US) 2007-09-18 US disclosed
US-7271270-B2 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION (US) 2007-09-18 US disclosed
US-20070027158-A1 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION 2007-02-01 US disclosed
US-20070027158-A1 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027158-A1 High affinity small molecule C5a receptor modulators C3AR1, C5AR1, C5AR2 ALDH1A1 4042/4885KDM4E 3927/4885HPGD 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.